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SOME biological parameters before and after an acute
episode of cigarette smoking in rats have been evaluated.
The carboxyhaemoglobin levels depended either on the
number of cigarettes, or on the time of exposure to
cigarette smoke and returned to pre-smoking values in
about 2 h. The evaluation of the kinetics of alveolar and
peritoneal macrophages in rats after a smoking session of
three cigarettes within an hour, indicated that alveolar
macrophages in the bronchoalveolar lavage fluid sign-
ificantly increased 8 h after the smoking, whereas the
number of peritoneal macrophages remained practically
constant. The incubation of these cells for various times
at 37C in a humidified atmosphere, resulted in
a spontaneous release, 24 h thereafter, of variable amounts
of tumour necrosis factor (TNF), which remained
practically constant during the following days. Neither
alveolar macrophages of control rats, nor peritoneal
macrophages of both control and smoking rats were
able to release TNF. Moreover, after lipopolysaccha-
ride induction of alveolar macrophages ofboth control and
smoking rats, an increased release ofTNF was observed,
indicating that these cells were in an active state.
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Introduction
Cigarette smoking is a useful human model of
chronic inflammation and it is well known that
inflammation may contribute to the destruction and
remodelling of normal lung architecture. Cigarette
smoking, exposing the surface of the lower
respiratory tract to more than 4000 chemical
constituents,
2 has been associated with an inflam-
matory process.
3 Moreover, inflammation leads
to an emigration, either of monocytes or
polymorphonuclear cells, from the vasculature to
the tissue. Alveolar macrophages, which are derived
from blood monocytes, exert their inflammatory
activities at the various sites either directly, or
through the action of tumour necrosis factor (TNF)
and other immunological mediators.
4 TNFz is
chemotactic for monocytes and polymorphonucle-
ate cells (PMN), stimulates phagocytosis, causes
adherence to endothelium and production of
oxygen-derived metabolites, induces procoagulant
activities in cultured human endothelial cells, and
activates macrophages resulting in interleukin-1 and
prostaglandin E2 production.
4-6 Thus the locally
regulated generation of TNFz at sites of injury
represents an important autocrine-paracrine control
mechanism which operates in acute inflammatory
response.
4
Evaluation of the acute effect of cigarette
smoking in human non-smokers is uncertain
because they do not inhale cigarette smoke deeply.
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For this reason research has been carried out to
study either the acute effect of cigarette smoking in
human smokers, or in small animals, or the effect
of cigarette smoke in blood cells in vitro.9’1
Assuming that the activation of macrophages is an
important event for the pleiotropic effects of these
cells, the present study was undertaken to
investigate some biological parameters after acute
tobacco smoking and the ability of cigarette smoke
to activate rat alveolar macrophages, thus causing
the release of TNFo. We also examined whether the
release of TNF by alveolar macrophages of rats
exposed to an episode of acute, passive cigarette
smoking, would be influenced by the presence of
lipopolysaccharide (LPS).
Materials and Methods
Animals: Outbred Wistar male rats (Charles River)
of about 280 g body weight were used throughout
the experiments. Groups of six rats were each
lodged in the smoke chamber for various periods
of time as indicated in Table 1. Smoke was
generated in the smoke apparatus using a varied
number of cigarettes without filter (Camel). This
particular brand was chosen only because it is an
internationally known brand of cigarettes. Immedi-
ately after smoking (0 h) and after 2, 4, 8 and 24 h,
animals were sacrificed by an overdose of nembutal
(Serva, Heidelberg). Blood was withdrawn from the
femoral vein with an insulin type syringe containing
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Table 1. Correlation between number of cigarettes, smoking
period and COHb blood levels in rats measured immediately after
the smoking session
Smoking (h) Cigarettes (n) Rats (n) COHb (%)
2 6 17.1 _+2.2
3 8 16.4 + 3.6
6 9+2.5
0 0 4 -1 _+1.1
10 IU/ml of heparin (Liquemin, Roche), for the
measurement of carboxyhaemoglobin (COHb), by
reading the absorbance at 276.5 nm in a spec-
trophotometer (Spectra Comp.601, Carlo Erba).
Afterwards, 10ml of sterile Hanks’ balanced
solution, pH 7.4, containing 5 IU/ml heparin was
injected into the peritoneal cavity, the abdomen was
gently massaged and then about 7 ___
1 ml of
peritoneal fluid (PF) was aspirated for the collection
of peritoneal macrophages.
Bronchoalveolar lavage was performed in the
rats through a catheter inserted into the trachea
with heparinized (10 IU/ml) sterile Hanks’ solution.
Five washes of 10 ml each were carried out in rapid
succession and the lavage fluids were pooled.
Recovery was about 90%. Lavage fluid was then
centrifuged at 300 g for 10min at 4C
and the sedimented cells shown to be macrophages
(more than 95%) by nonspecific esterase staining.
Separated macrophages were tested for viability by
the Trypan blue exclusion method and more than
95% of cells were found to be viable. The number
of macrophages was evaluated by at least three
countings in a Biirker chamber.
Control animals (air-sham exposed rats) were
subjected to the same procedure except that the
chamber was insulated with air only.
Cell culture" For the experiments evaluating the
eventual production of TNF0, cells from BAL and
PF, collected immediately after (0 h) and 4, 8 and
24 h after the smoking session of three cigarettes
for 1 h, were diluted to the desired final
concentration (106 cells/ml) with RPMI 1640
containing 10% heat-inactivated foetal calf serum
(FCS), 2 mM glutamine, 100 U/ml penicillin G and
100 #g/ml streptomycin. One hundred microlitres
of the cell suspensions (about 105 cells) were added
to each well in 96-well culture plates (Costar) and
were incubated for 24, 48 and 72 h at 37C in a
humidified atmosphere (95% air/5% CO2). A second
batch of cells, collected 0, 8 and 24 h after the
smoking session and layered as above, was
challenged with 1/g/ml bacterial lipopolysacchar-
ide (LPS) from Escherichia coli (Sigma)and
incubated for 24 h at 37C. Then the plates were
centrifuged and supernatants were stored at -80C
until TNF was determined.
Sediments, after two washings with normal
saline, were dissolved in 0.1 N NaOH (0.1 ml per
well, 12 h at room temperature) and proteins were
measured by the method ofLowry et al.
11 with some
modifications.
TNF determination" TNF activity was determined
by the method of Ruff" and Gifford
12 with some
modifications. Briefly, L929 cells were seeded at a
density of 4 104 cells per well in 96-well culture
dishes in 100/1 of Eagle’s MEM supplemented
with 10% FCS and antibiotics. After 4 h incubation
at 37C in a humidified atmosphere (95%
air/5%CO2), two-fold serial dilutions of the
samples in 2/g/ml of actinomycin D (Serva), were
prepared in separate 96-well culture dishes. Then
100/1 of each dilution was transferred into the
corresponding well and the plates were further
incubated for 18 h at 37C in the humidified
atmosphere. Supernatants were then removed and
cells stained with 0.1% crystal violet. After drying,
100/1 of 33% acetic acid was added to each well to
dissolve the dye. Plates were finally read at 540 nm
on a Titertek Multiskan microElisa reader. Units of
TNF activity were defined as the reciprocal of the
dilution causing 50% of maximum cytotoxicity.
Human Recombinant TNF0 (Biogen BASF/Knoll)
with a specific activity of 1.5 107units/mg
protein was used as internal standard.
Statistical analysis: TNF0 activity is reported as
units/mg protein, 1 mg protein corresponding to
1.7 __+ 0.5 x 107 cells. Evaluation of experimental
data was performed using either Mann-Whitney’s
U test or two-tailed Student’s t-test withp _< 0.05 as
the minimal level of significance.
Results
Because of the lack of a readily and simply
measurable marker of environmental tobacco
smoke, COHb levels were assessed as a reliable
indicator of the biological eflects of cigarette
smoking. Normally in non-smokers, the average of
basal COHb levels was --1 +__ 1.1 and, as shown in
Table 1, COHb levels critically depended on both
the number of cigarettes and the time of
exposure to cigarette smoke. The decay of COHb
in the blood of the rats was also evaluated after they
had smoked three cigarettes for 1 h and after they
were returned to the normal environment. As
shown in Fig. 1 the COHb reached the maximum
at the end of the smoking session but in about 2 h
returned to pre-smoking values. The evaluation of
the kinetics of alveolar and peritoneal macrophages
was carried out in rats that, after undergoing
smoking (three cigarettes within a hour), showed a
COHb increase up to 16.4%. Figure 2 (panel A)
indicates that the total number of macrophages
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FIG. 1. Kinetics of COHb in the blood of rats during and after a smoking
session (three cigarettes for h). Arrows indicate the beginning and the
end of the smoking session.
present in the bronchoalveolar lavage significantly
increased 8 h after smoking (U _< 0.05) in respect
to control rats (Fig. 2, panel B). On the other hand
the number of peritoneal macrophages remained
practically constant in both smokers and controls
(Fig. 2, panels A and B). An increase of
polymorphonuclear cells (PMN) in the broncho-
alveolar lavage was also observed at 8 and 24 h after
an acute smoking episode but it was not statistically
significant (data not shown).
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FIG. 2. Kinetics of alveolar (O) and peritoneal (@) macrophages in rats
after a smoking session of three cigarettes for h (panel A) and in
controls (panel B). Arrows indicate the beginning and the end of the
smoking session.
Table 2. TNF (U/mg protein) expressed as mean-I-S.D.
released by alveolar macrophages collected various times after
the smoking session and incubated for 24, 48 and 72 h at 37C
Incubation at 37C (h)
Time after
smoking (h) 24 48 72
0 88 _+ 32 90 _+ 40 76 _+ 31
4 310 -I- 151 283 _+ 184 320 _+ 150
8 525 +_ 210 455 +_ 210 465 +_ 215
24 235 _+ 106 250 _+ 150
Controls < 10 < 10 < 10
The appraisal of the kinetics of alveolar
macrophages after acute smoking compelled us to
evaluate the eventual activity of these cells by
measuring the release of TNF0. As shown in Table
2, alveolar macrophages, collected at various times
after acute smoking and incubated for 24, 48 and
72h at 37C in a humidified atmosphere,
spontaneously released variable amounts of TNF0,
which were higher 8 h after the smoking session.
Moreover TNF0 production increased up to 24 h
and varied little in the following days of incubation
(Table 2). Neither alveolar macrophages of air-sham
exposed rats, nor peritoneal macrophages of both
control and smoking rats were able to release
TNF0, which was also absent either in the
supernatants of BAL and PL or in plasma. When
alveolar macrophages of control and smoking rats,
collected 0, 8 and 24 h after the smoking session
and incubated for 24 h at 37C, were challenged
with LPS, they released much more TNF0 (Fig. 3)
but, in such a case, the TNF0 release was
significantly lower for the smoking group with
respect to the control rats.
Discussion
These studies provide data on the short-term effects
of acute cigarette smoking in rats. It is known that
cigarette smoking in rabbits and in man causes a
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FIG. 3. TNF units/mg proteins expressed as mean -t- S.D. released after
induction with LPS by alveolar macrophages collected from smoker
(empty columns) and control rats (narrow right diagonal columns) 0, 8
and 24 h after the smoking session.
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rapid increase of COHb8-13 and on this basis a wide
range of conditions has been explored yielding a
COHb increase from --1 up to 17% in rats. COHb
is a reliable marker and the interanimal variability
appears small. In the present experimental condi-
tions, reproducibility among dierent experiments
is within 10%. In order to be sure of the acute effect,
we selected the protocol of smoke exposure of
three cigarettes within an hour for the experiments
evaluating the active state of alveolar macrophages.
This gave COHb levels of about 16%, returning to
pre-smoke values 2 h after the smoking session. The
evaluation of the kinetic of alveolar macrophages
collected from BAL after the smoking session,
indicated a significant increase 8 h after the smoke
episode and a little increase of PMN probably due
to chemotactic factors14’15 At the same time alveolar
macrophages, incubated at 37C in a humidified
atmosphere, spontaneously released TNF. Al-
though TNFo release by alveolar macrophages was
observed either in rats with silicosis
16 and mice
infected with influenza virus,
17 or in man as a
consequence of Sepsis Syndrome
18 and Adult
Respiratory Distress Syndrome,
19 our results
demonstrated for the first time that alveolar
macrophages, collected after an acute smoking
episode, were in an active state and spontaneously
released TNF. The absence of this cytokine in the
BAL could be due to both the dilution and the short
time for the cell collection. Additionally, the
absence of TNFo in plasma could be explained by
both the dilution in body fluids and the rapid
clearance of this substance.2’21 At a later date the
eventual local catabolism ofTNFo will be reported.
Peritoneal macrophages, representing a resident
population remote from the primary site of smoke
and perhaps not having direct contact with smoke
pollutants and products, were unable to spontan-
eously release TNFo. This clearly indicates that
these cells were in a resting state. However,
differences in regulation of TNF production by
either human,
22 or murine
23 alveolar macrophages
stimulated with LPS are well known.
Finally we wanted to ascertain whether a classical
inducer such as LPS antagonizes or synergizes with
the eect of smoke on alveolar macrophages. It was
found that alveolar macrophages collected from
control rats released much more TNFo than those
collected from smokers, probably because of a
negative feed-back and enhanced breakdown due to
proteinases released during the incubation period.
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